Hypoxia driven opioid targeted automated device for overdose rescue.

Abstract

Opioid use disorder has been designated a worsening epidemic with over 100,000 deaths due to opioid overdoses recorded in 2021 alone. Unintentional deaths due to opioid overdoses have continued to rise inexorably. While opioid overdose antidotes such as naloxone, and nalmefene are available, these must be administered within a critical time window to be effective. Unfortunately, opioid-overdoses may occur in the absence of antidote, or may be unwitnessed, and the rapid onset of cognitive impairment and unconsciousness, which frequently accompany an overdose may render self-administration of an antidote impossible. Thus, many lives are lost because: (1) an opioid overdose is not anticipated (i.e., monitored/detected), and (2) antidote is either not present, and/or not administered within the critical frame of effectiveness. Currently lacking is a non-invasive means of automatically detecting, reporting, and treating such overdoses. To address this problem, we have designed a wearable, on-demand system that comprises a safe, compact, non-invasive device which can monitor, and effectively deliver an antidote without human intervention, and report the opioid overdose event. A novel feature of our device is a needle-stow chamber that stores needles in a sterile state and inserts needles into tissue only when drug delivery is needed. The system uses a microcontroller which continuously monitors respiratory status as assessed by reflex pulse oximetry. When the oximeter detects the wearer's percentage of hemoglobin saturated with oxygen to be less than or equal to 90%, which is an indication of impending respiratory failure in otherwise healthy individuals, the microcontroller initiates a sequence of events that simultaneously results in the subcutaneous administration of opioid antidote, nalmefene, and transmission of a GPS-trackable 911 alert. The device is compact (4 × 3 × 3 cm), adhesively attaches to the skin, and can be conveniently worn on the arm. Furthermore, this device permits a centralized remotely accessible system for effective institutional, large-scale intervention. Most importantly, this device has the potential for saving lives that are currently being lost to an alarmingly increasing epidemic.

• Authors: Mohammad S Imtiaz, Charles V Bandoian, Thomas J Santoro
• Journal: Scientific reports (Sci Rep) Vol. 11 Issue 1 Pg. 24513 (12 31 2021) ISSN: 2045-2322 [Electronic] England
• PMID: 34972818 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s).

Chemical References

• Analgesics, Opioid
• Narcotic Antagonists
• Naloxone

Topics

• Analgesics, Opioid (adverse effects)
• Disease Management
• Drug Delivery Systems (instrumentation, methods)
• Drug Overdose
• Equipment Design
• Humans
• Hypoxia (metabolism)
• Naloxone (administration & dosage)
• Narcotic Antagonists (administration & dosage)
• Opioid-Related Disorders (diagnosis, etiology, metabolism, therapy)
• Treatment Outcome
• Wearable Electronic Devices